New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:10 EDTMBII, EVGNEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration
News For EVGN;MBII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
10:00 EDTMBIIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Achillion (ACHN) downgraded on valuation at JMP Securities... Ashland (ASH) downgraded to Equal-Weight from Overweight at First Analysis... Bank of Nova Scotia (BNS) downgraded to Underperform from Neutral at BofA/Merrill... Braskem (BAK) downgraded to Neutral from Overweight at JPMorgan... Comerica (CMA) downgraded to Underperform at Baird... Crestwood Midstream (CMLP) downgraded to Neutral from Buy at Ladenburg... Fifth Third (FITB) downgraded to Neutral from Outperform at Baird... Keurig Green Mountain (GMCR) downgraded to Hold from Buy at Argus... Keysight Technologies (KEYS) downgraded to Neutral from Outperform at Baird... Leju (LEJU) downgraded to Underperform from Buy at CLSA... Marrone Bio (MBII) downgraded to Hold from Buy at Jefferies... Southwest (LUV) downgraded to Neutral from Buy at Buckingham... SunTrust (STI) downgraded to Market Perform from Outperform at Keefe Bruyette... Western Alliance (WAL) downgraded to Market Perform from Outperform at Keefe Bruyette.
08:04 EDTMBIIMarrone Bio downgraded to Hold from Buy at Jefferies
Jefferies downgraded Marrone Bio Innovations to Hold with a $2.25 price target after the company said it is evaluating restatements.
May 19, 2015
07:06 EDTEVGNEvogene reports Q1 EPS (13c), one estimate (20c)
Subscribe for More Information
May 18, 2015
17:09 EDTMBIIMarrone Bio evaluating the necessity, nature and scope of any restatements
Subscribe for More Information
16:55 EDTMBIIMarrone Bio provides update on NASDAQ matters
Subscribe for More Information
May 12, 2015
17:17 EDTMBIIMarrone Bio to delay filing Form 10-Q
Marrone Bio Innovations announced that on May 6, as anticipated, the company was notified by the Listing Qualifications Staff of The NASDAQ Stock Market that, based upon the company’s continued non-compliance with NASDAQ’s filing requirements under NASDAQ Listing Rule 5250(c)(1), the uncertainty of the company’s time frame to file all its required periodic reports and its expectation that it would not file all periodic reports with the SEC by May 13, the termination of the exception period previously granted by the Staff, the company’s securities were subject to delisting unless the Company timely requests a hearing before the NASDAQ Listing Qualifications Panel. In addition, the company announced that it does not expect to file on a timely basis its Quarterly Report on Form 10-Q for the three months ended March 31, resulting in further noncompliance with NASDAQ Listing Rule 5250(c)(1). The company intends to timely request a hearing before the Panel, at which hearing the company will present its plan to evidence compliance with NASDAQ’s filing requirement and request an extension within which to do so. In accordance with the NASDAQ Listing Rules, the Panel has the authority to continue the company’s listing on NASDAQ pursuant to an exception to the filing requirement through as late as November 2. The company’s common stock will continue to trade on The NASDAQ Global Market under the symbol “MBII” pending the completion of the hearing process and the expiration of any extension period granted by the Panel.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use